Mid-Week Coffee Break - P&L Scientific Inc.

Virtual technology talk between IVAM Members
Apr 15, 2026, 9:00 a.m. - 10:00 a.m.
members-only virtual
Zoom Meeting

Curious about new technologies and fresh impulses from the IVAM network?

The Mid-Week Coffee Break brings IVAM members together online every four weeks to explore new ideas, share perspectives, and build connections within the network.

Each session starts with a short, inspiring impulse from the IVAM network, followed by open exchange, questions, discussion, and personal networking.

We meet regularly on the third Wednesday of each month — easy to join, engaging, and focused on what really matters: people, ideas, and meaningful exchange.

IVAM warmly invites you to the next Mid-Week Coffee Break:

🗓 April 15, 2026
🕘 09:00–10:00 a.m. (CET)
💻 Online via Zoom

This time, we are especially pleased to welcome P&L Scientific Inc. as our host.
In a compact impulse talk, Mr. Jun Peng will share insights into:

„Overview and Market Entry of US Healthcare Devices Market"

 

Look forward to practical insights, fresh perspectives, and direct exchange with fellow IVAM members.

👉 Participation is free of charge for IVAM members — registration via the ticket shop.  

 

Interested in hosting a future Mid-Week Coffee Break or bringing your own topic to the IVAM community?
Feel free to get in touch at membership@ivam.de!

Speakers


Your Contact

Alice Kasjanow
Membership Relations Manager
+49 (0) 231 9742 168

Further events

May 20, 2026, 9:00 a.m. - 10:00 a.m.
Virtual technology talk between IVAM Members
Mar 3 - 5, 2027
Discover the Future of Photonics with IVAM
Feb 9 - 11, 2027
Medical Design & Manufacturing - IVAM presents Micro Nanotech Area in Hall C

Recommended news

Apr 1, 2025

The technical program for the IVAM Hightech Summit 2025, taking place on May 21–22 at Signal Iduna Park in …

Feb 17, 2026

Autonomous systems, robotics and high-tech components take center stage: At XPONENTIAL Europe 2026 in March, IVAM will for the first …

Feb 15, 2026

CorTec has completed the second successful implantation of its fully implantable brain-computer interface system as part of an FDA-approved clinical …